Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Iaterion Inc. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The case is assigned to 1 distinct examiner, SHOMER, ISAAC, who is also the busiest examiner for the company. The presence of 1 pending action indicates the current scale of the company's active prosecution.
The activity is concentrated in 1 distinct art unit. SHOMER, ISAAC is the busiest examiner for the company, with 1 pending action. This concentration in 1 distinct art unit suggests a specific technical focus. Practitioners should note that the company's current interactions with the patent office are centralized under this 1 distinct examiner. The outcome of the pending office action will define the company's immediate success in the Biotechnology & Pharmaceuticals field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHOMER, ISAAC | 1 | 63.2% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026567 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | SHOMER, ISAAC | 10d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026567 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | SHOMER, ISAAC | 10d overdue |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18026567 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | SHOMER, ISAAC | 1612 | §102§103Other | Non-Final OA | 10d overdue | Pending | Mar 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial